Analystreport

Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM) had its price target raised by analysts at Morgan Stanley from $33.00 to $53.00. They now have an "overweight" rating on

Rhythm Pharmaceuticals, Inc.  (RYTM) 
Last rhythm pharmaceuticals, inc. earnings: 3/8 08:12 am Check Earnings Report
US:NASDAQ Investor Relations: ir.rhythmtx.com